Trade

Albert David share price

High risk
  • 51%Low risk
  • 51%Moderate risk
  • 51%Balanced risk
  • 51%High risk
  • 51%Extreme risk
  • 916.20(-2.63%)
    July 15, 2025 15:16:04 PM IST
    • NSE
    • BSE
  • Vol : 4.95K (NSE + BSE)
    Last 20 day avg : 9.21 K

Albert David is trading -2.63% lower at Rs 916.20 as compared to its last closing price. Albert David has been trading in the price range of 945.10 & 915.60. Albert David has given -29.02% in this year & 1.99% in the last 5 days. Albert David has TTM P/E ratio 26.81 as compared to the sector P/E of 23.29.The company posted a net profit of -10.33 Crores in its last quarter.Listed peers of Albert David include Nectar Lifesciences (-4.96%), Zim Laboratories (1.19%), Albert David (-2.63%).The Mutual Fund holding in Albert David was at 0.01% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Albert David was at 1.00% in 31 Mar 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Jul 15, 2025, 05:39 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.53
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.38
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    31.41
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.68
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.03
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
915.60
Highest
945.10
52 week range
Lowest
763.90
Highest
1,752.95
Albert David Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is not profitable
    • financial-insightsThe company's revenue fell during March quarter by 15.90% from Rs 89.06 crore to Rs 74.89 crore, year-on-year
    • financial-insightsCompany has registered a loss of 10.33 cr vs a profit of 12.91 cr in the same quarter last year.
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsEarnings are insufficient to cover the interest expenses on outstanding debt
Albert David Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 919.03
  • R2
  • 1,002.37
  • R3
  • 1,045.38
Pivot876.02
  • S1
  • 792.68
  • S2
  • 749.67
  • S3
  • 666.33
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Albert David Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Nectar Lifesciences
Bearish
18.00-4.96403.67105.550.49-13.12
Zim Laboratories
Bullish
114.901.19563.7542.862.08-16.80
Albert David
Moderately Bullish
916.20-2.63527.6229.511.290.560.34
Vikram Thermo India
Bearish
153.000.92479.6223.573.980.491.80
Oxygenta Pharmaceutical
Neutral
109.100.60403.49---
Albert David Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Albert David is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 62.24%
    • InsightsPromoter(s) have increased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 0.14 percentage points from previous quarter
    • InsightsMutual Funds holding is constant over the last quarter at 0.01%
    Albert David Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-13Audited Results & Final Dividend
    2025-02-12Quarterly Results
    2024-11-14Quarterly Results
    2024-08-09Quarterly Results
    2024-05-13Audited Results & Final Dividend
    About the company Albert David
    • IndustryBiotechnology & Drugs
    • ISININE155C01010
    • BSE Code524075
    • NSE CodeALBERTDAVD
    Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
    • Management Info
    • Arun KothariExecutive Chairman of the Board
    • Umesh KunteChief Executive Officer, Managing Director
    • Ranadeep BhattacharyaChief Financial Officer
    • Lalit LohiaChief Compliance Officer, Company Secretary
    • S. BhattacharyaPlant Head, Kolkata
    • A. J. ChattopadhyayCorporate Head – Human Resources
    • Anirban GhoshHead of Sales & Marketing
    • Ashis MajumdarHead of Sales & Marketing
    • H. T. NazarePlant Head, Ghaziabad
    Albert David Share Price FAQs

    Albert David is trading at 916.20 as on Tue Jul 15 2025 09:46:04. This is -2.63% lower as compared to its previous closing price of 940.90.

    The market capitalization of Albert David is 527.62 Cr as on Tue Jul 15 2025 09:46:04.

    The 52 wk high for Albert David is 1752.95 whereas the 52 wk low is 763.90

    Albert David can be analyzed on the following key metrics -

    • TTM P/E: 26.81
    • Sector P/E: 23.29
    • Dividend Yield: 0.53%
    • D/E ratio: 0.03

    Albert David reported a net profit of 17.20 Cr in 2025.

    The Mutual Fund Shareholding was 0.01% at the end of 31 Mar 2025.